US approves first drug for severe form of fatty liver disease
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
Mar 15, 2024
0
3
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
Mar 15, 2024
0
3
Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is spectrum of diseases that ranges from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis ...
Jan 22, 2024
0
0
According to a study conducted on animal models and published in the journal Metabolism, aerobic exercise could help fight non-alcoholic fatty liver disease, the most common liver disease worldwide: it affects nearly 24% ...
Jan 22, 2024
0
1
The global rise in obesity and diabetes is leading to an epidemic in fatty liver disease affecting 20%–30% of the world's population. Almost a third of people with fatty liver disease go on to develop an advanced form of ...
Dec 7, 2023
0
0
An international clinical trial involving Birmingham Professor Phil Newsome identified a promising target for patients with non-alcoholic steatohepatitis (NASH), as reported in a paper published yesterday (Nov. 6) in Nature ...
Nov 7, 2023
0
41
A new research paper titled "Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients" has been published inAging.
Sep 26, 2023
0
0
A breakthrough study, jointly led by Professor Jang Hyun Choi and Professor Sung Ho Park from the Department of Biological Sciences at UNIST has identified an important factor involved in the development of non-alcoholic ...
Sep 6, 2023
0
2
Chronic liver injury results in the development of liver fibrosis in approximately 25% of individuals in response to diverse insults, and several aspects of the development of liver injury appear to be common to a variety ...
Aug 31, 2023
0
0
About 2% of adults worldwide suffer from a condition called non-alcoholic steatohepatitis (Nash), an advanced form of non-alcoholic fatty liver disease. This occurs when fat builds up in the liver, causing inflammation and ...
Jul 3, 2023
0
9
Metabolic (bariatric) surgery is more effective than medications and lifestyle interventions for the treatment of advanced non-alcoholic fatty liver disease.
Apr 20, 2023
0
113